Early Detection Research Network

Biomarkers: the key to early detection

Navigation

Personal tools

You are here: Home / Protocols / Biomarker Dev Lab At Moffitt Supplement

Abbreviated Name: Biomarker Dev Lab At Moffitt Supplement

Protocol ID: 72

Lead Investigator: Tockman, Melvyn S. — H. Lee Moffitt Cancer Center

Coordinating Investigator:

No coordinating investigator defined.

Involved Investigator Sites:

Biomarker Name:

Design:

Field(s) of Research: UNKNOWN

Collaborative Group Text: Lung and Upper Aerodigestive Cancers Research Group

Phased Status:

Abstract:

Aims:

Analytic Method:

Comments:

Biomarkers:

There are currently no biomarkers annotated for this protocol.

Datasets:

No datasets are currently associated with this protocol.

: Announcement 7/2/2018

The 33rd EDRN Steering Committee Meeting is from September 5-6, 2018 in Boston, MA. Please click here for meeting registration and hotel information.

The 34th EDRN Steering Committee is from March 18-20, 2019 in Nashville TN.; Announcement 6/1/2018

Dr. Sudhir Srivastava was honored with the 2017 Human Proteome Organization (HUPO) Award for a Distinguished Scientist in Clinical and Translational Proteomics. Please join us in congratulating him on his accomplishments and contributions. The awards were presented at HUPO 2017 in Dublin, Ireland and the winners were present to provide a small talk during the Awards Ceremony and HUPO Lectures.